Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Peptidomimetic design

A S Ripka1, D H Rich

  • 1Department of Chemistry and School of Pharmacy, University of Wisconsin-Madison 53706, USA.

Current Opinion in Chemical Biology
|September 16, 1998
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhancement in the excitonic spontaneous emission rates for Si nanocrystal multi-layers covered with thin films of Au, Ag, and Al.

Nanotechnology·2015
Same author

Observations of exciton-surface plasmon polariton coupling and exciton-phonon coupling in InGaN/GaN quantum wells covered with Au, Ag, and Al films.

Journal of physics. Condensed matter : an Institute of Physics journal·2015
Same author

Biological activities of non-immunosuppressive cyclosporin analogs.

IDrugs : the investigational drugs journal·2005
Same author

Facile degradative lactonization of Gln-Arg and Gln-Phe hydroxyethylene dipeptide derivatives.

The journal of peptide research : official journal of the American Peptide Society·2005
Same author

Synthesis of substrates and inhibitors of botulinum neurotoxin type A metalloprotease.

The journal of peptide research : official journal of the American Peptide Society·2004
Same author

Solid-phase synthesis of aspartic peptidase inhibitors: 3-alkoxy-4-aryl piperidines.

Organic letters·2001

New peptidomimetic inhibitors targeting peptide-derived systems have been discovered. These innovative reversible inhibitors show promise for various enzymes, including proteases and renin.

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Biochemistry

Background:

  • Peptide-derived systems are crucial in biological processes.
  • Developing inhibitors for these systems presents significant therapeutic potential.
  • Existing inhibitors often face challenges with stability and bioavailability.

Purpose of the Study:

  • To report the discovery of novel type-I and type-III peptidomimetic inhibitors.
  • To explore the development of reversible inhibitors for key enzymes.
  • To expand the repertoire of peptidomimetic inhibitors for therapeutic targets.

Main Methods:

  • Design and synthesis of novel peptidomimetic compounds.
  • Evaluation of inhibitory activity against target enzymes.
  • Characterization of inhibitor properties, including reversibility.

Related Experiment Videos

Main Results:

  • Discovery of new type-I and type-III peptidomimetic inhibitors.
  • Identification of innovative reversible inhibitors for cysteine proteases and renin.
  • Demonstration of peptidomimetic inhibition against a broad range of enzymes including HIV protease, Factor Xa, and aspartic proteases.

Conclusions:

  • Peptidomimetic inhibitors represent a promising strategy for targeting peptide-derived systems.
  • The newly discovered inhibitors offer potential for therapeutic intervention in various diseases.
  • Further development of these inhibitors could lead to novel drug candidates.